ArticleClinical pharmacokinetics2018

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.

Stein Schalkwijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.